Tag: Survival

However, childhood cancer survivors have lower risk for registered COVID-19 infection relative to comparators

Better posttreatment pathology and similar overall survival seen for stereotactic ablative radiotherapy group despite more advanced disease

Introduction of immune checkpoint inhibitors linked to widening disparity for those with private insurance versus those without insurance

Increasing neighborhood marginalization linked to higher rates of mortality beginning at 30 days after discharge

Addition of neoadjuvant and adjuvant pembrolizumab to standard care significantly improves event-free survival

In study, patients with CRC as the only malignancy had more frequent liver and lung metastases and received systemic adjuvant treatments more often

However, poor social determinants of health group demonstrated better survival rates at both 90 days and one year

Medicare beneficiaries undergoing concomitant surgical ablation have risk-adjusted median survival advantage

Longer mean duration of quality-adjusted time without symptoms of disease progression or toxicity of treatment seen with dostarlimab

No reduction seen in risk with adjuvant regional nodal irradiation among patients with node-positive breast cancer who reached ypN0 status after neoadjuvant chemo